Physician profile
Subinoy Das
NPI 1063461663
$141,590.04
in general payments reported to CMS, 2019-2025
18 companies · $48K in 2025
The $48K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,636 · 2020: $774 · 2021: $534 · 2022: $29K · 2023: $13K · 2024: $43K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $79K · Consulting Fee: $9,710 · Travel and Lodging: $9,588 · Food and Beverage: $5,372 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $79,405.00 |
| Consulting Fee | $9,710.00 |
| Travel and Lodging | $9,587.81 |
| Food and Beverage | $5,372.31 |
| Education | $193.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $122,688.81 | 2021-2025 | |
| Medtronic USA, INC. | $6,669.37 | 2019-2020 | |
| Glaxosmithkline, LLC. | $6,206.47 | 2023-2025 | Nucala, Arexvy |
| Stryker Corporation | $1,468.04 | 2019-2025 | Scopis Ent, Xpress Loprofile, Xpress Ent Dilation System |
| Aerin Medical INC. | $1,450.70 | 2022-2023 | |
| Abbvie INC. | $956.59 | 2022-2025 | Ubrelvy, Qulipta |
| Regeneron Healthcare Solutions, INC. | $432.03 | 2023-2025 | Dupixent |
| Medtronic, INC. | $353.69 | 2021-2025 | Abre, Propel |
| Genzyme Corporation | $342.22 | 2019-2025 | |
| Pfizer INC. | $234.97 | 2024-2025 | |
| Horizon Therapeutics Plc | $222.00 | 2021-2022 | |
| Intersect Ent, INC. | $173.64 | 2019-2021 | |
| Acclarent, INC | $167.20 | 2019-2023 | Acclarent Balloon Inflation Device |
| Grace Medical, INC. | $153.73 | 2024 | |
| Pharming Healthcare, INC. | $20.11 | 2023 | Ruconest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $19.50 | 2025 | Xhance |
| Inspire Medical Systems, INC. | $16.24 | 2024 | Inspire |
| Amgen INC. | $14.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subinoy Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.